Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 327, Issue 7, Pages 639
Publisher
American Medical Association (AMA)
Online
2022-01-22
DOI
10.1001/jama.2022.0470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Risk Factors Associated With COVID-19 Transmission Among US Air Force Trainees in a Congregant Setting
- (2021) Joseph E. Marcus et al. JAMA Network Open
- Can the cycle threshold (Ct) value of RT-PCR test for SARS CoV2 predict infectivity among close contacts?
- (2021) Soha Al Bayat et al. Journal of Infection and Public Health
- Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
- (2021) Wanwisa Dejnirattisai et al. LANCET
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
- (2021) Stephen M. Kissler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Track Omicron’s spread with molecular data
- (2021) Lesley Scott et al. SCIENCE
- SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021
- (2021) MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Community-Based Testing Sites for SARS-CoV-2 — United States, March 2020–November 2021
- (2021) Mark F. Miller et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
- (2021) Sarah Mbaeyi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
- (2021) Peter J. Embi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
- (2021) Ying P. Tabak et al. JAMA Network Open
- Predicting infectious SARS-CoV-2 from diagnostic samples
- (2020) Jared Bullard et al. CLINICAL INFECTIOUS DISEASES
- Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
- (2020) Anika Singanayagam et al. Eurosurveillance
- Epidemiological Correlates of PCR Cycle Threshold Values in the Detection of SARS-CoV-2
- (2020) Phillip P Salvatore et al. CLINICAL INFECTIOUS DISEASES
- Test-Negative Designs
- (2019) Jan P. Vandenbroucke et al. EPIDEMIOLOGY
- The Use of Test-negative Controls to Monitor Vaccine Effectiveness
- (2019) Huiying Chua et al. EPIDEMIOLOGY
- The impact of selection bias on vaccine effectiveness estimates from test-negative studies
- (2018) Michael L. Jackson et al. VACCINE
- Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness
- (2016) Sheena G. Sullivan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now